Oxford BioDynamics PLC
Oxford BioDynamics (OBD) is a biotechnology company specializing in the development of epigenetic biomarker tests for the diagnosis and treatment of various diseases, particularly in the fields of oncology and autoimmune disorders. The company leverages its proprietary EpiSwitch® platform to identify and validate biomarkers that can be used in clinical settings, offering insights that enhance personalized medicine. OBD operates primarily within the life sciences sector, focusing on research and clinical applications that bridge the gap between genomic data and therapeutic outcomes.